Moderna and Merck have announced that late-stage trials of a personalised mRNA cancer vaccine for the treatment of melanoma have yielded positive results. The companies stated that the treatment reduced the risk of melanoma recurrence or spread when used in conjunction with Merck’s immunotherapy drug Keytruda. Notably, Keytruda is already widely used to treat melanoma and several other cancers. This…
Tag: Personalised Medicine
-
AI Health Prompts Drive Earlier Cancer Detection at Discovery
Discovery Life says AI-driven health prompts are helping clients detect serious illness earlier, including cancer. The insurer shared the update to highlight how incentives and personalised recommendations can shift health behaviour. Discovery Life, part of JSE-listed Discovery, has long linked rewards to healthy choices through its Vitality programme. Now it is expanding that approach with AI-led prompts. The insurer has…
-
Precision Medicine: Transforming Treatment Approaches
A quiet revolution is reshaping healthcare, shifting the focus from merely managing symptoms to fundamentally altering the course of complex diseases. At the forefront of this evolution are two critical fields: precision medicine in oncology and groundbreaking new treatments for severe mental health conditions like schizophrenia and treatment-resistant depression. These advancements signal a move away from one-size-fits-all approaches and towards…